Biopharma supplier finds success catering to R&D

The Philadelphia Inquirer profiles the growth of Lampire Biological Laboratories into a multimillion dollar supplier of reagents, antibodies, cell-culture devices and other products for the biopharma industry. The privately held company says it now has revenue well in excess of $10 million. Its client list includes Bristol-Myers, Pfizer and Schering-Plough.

- read the Philadelphia Inquirer profile

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

Pfizer's eczema hopeful has been building its case to challenge Sanofi and Regeneron's Dupixent, but safety issues could stand in its way.

Cedrik Britten, M.D., becomes the biotech’s new chief medical officer to help run its adoptive cell therapy and TCR bispecifics platform.